SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-774104
Filing Date
2016-11-22
Accepted
2016-11-21 20:59:13
Documents
69
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d241101d10q.htm 10-Q 754676
2 EX-31.1 d241101dex311.htm EX-31.1 5914
3 EX-31.2 d241101dex312.htm EX-31.2 6580
4 EX-32.1 d241101dex321.htm EX-32.1 3835
  Complete submission text file 0001193125-16-774104.txt   5241521

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crspr-20160930.xml EX-101.INS 732853
6 XBRL TAXONOMY EXTENSION SCHEMA crspr-20160930.xsd EX-101.SCH 63909
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crspr-20160930_cal.xml EX-101.CAL 66786
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crspr-20160930_def.xml EX-101.DEF 352573
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crspr-20160930_lab.xml EX-101.LAB 534544
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crspr-20160930_pre.xml EX-101.PRE 442253
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 162011620
SIC: 2836 Biological Products, (No Diagnostic Substances)